MOG antibody–associated longitudinal extensive myelitis after Oxford-Astra Zeneca’s COVID-19 vaccination

Wright, Sarah

doi:10.1177/13524585211066771

Search citation statements

Order By: Relevance

Paper Sections

Select...

Two Years Of Covid-19 In the Ms Community1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The association of neurological autoimmunity with infection or vaccination is hypothesized to be due to molecular mimicry or non-specific immune activation but causal relationship is hard to establish and further studies are needed. 24,25 At the current state of knowledge, SARS-CoV-2 vaccination is recommended as COVID-19 risk outweighs the risk of rare vaccine adverse events.…”

Section: Two Years Of Covid-19 In the Ms Communitymentioning

confidence: 99%

Two years of COVID-19 in the MS community: What have we learnt so far?

2022

View full text Add to dashboard Cite

Section: Two Years Of Covid-19 In the Ms Communitymentioning

confidence: 99%

Two years of COVID-19 in the MS community: What have we learnt so far?

2022

View full text Add to dashboard Cite

Safety of COVID-19 Vaccines: Spotlight on Neurological Complications

Tondo

Virgilio

Naldi

et al. 2022

Life

View full text Add to dashboard Cite

The COVID-19 pandemic has led to unprecedented demand on the global healthcare system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human use in several countries worldwide. Since then, a solid base for response in the fight against the virus has been placed. COVID-19 vaccines have been shown to be safe and effective drugs. Nevertheless, all kinds of vaccines may be associated with the possible appearance of neurological complications, and COVID-19 vaccines are not free from neurological side effects. Neurological complications of COVID-19 vaccination are usually mild, short-duration, and self-limiting. However, severe and unexpected post-vaccination complications are rare but possible events. They include the Guillain-Barré syndrome, facial palsy, other neuropathies, encephalitis, meningitis, myelitis, autoimmune disorders, and cerebrovascular events. The fear of severe or fatal neurological complications fed the “vaccine hesitancy” phenomenon, posing a vital communication challenge between the scientific community and public opinion. This review aims to collect and discuss the frequency, management, and outcome of reported neurological complications of COVID-19 vaccines after eighteen months of the World Health Organization’s approval of COVID-19 vaccination, providing an overview of safety and concerns related to the most potent weapon against the SARS-CoV-2.

show abstract

MOG antibody–associated longitudinal extensive myelitis after Oxford-Astra Zeneca’s COVID-19 vaccination

Cited by 2 publications

References 5 publications

Two years of COVID-19 in the MS community: What have we learnt so far?

Two years of COVID-19 in the MS community: What have we learnt so far?

Safety of COVID-19 Vaccines: Spotlight on Neurological Complications

Contact Info

Product

Resources

About